73Indexed trials
canonical disease area
Migraine / Headache
Intelligence
Migraine / Headache intelligence: 73 indexed trials, 15 recruiting studies, 59 sponsors across 44 countries.
15Recruiting
59Sponsors
44Countries
Leading sponsors
AbbVie54 recruiting
Eli Lilly and Company40 recruiting
Pfizer30 recruiting
H. Lundbeck A/S31 recruiting
HealthPartners Institute20 recruiting
ElectroCore INC20 recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine21 recruiting
Autonomic Technologies, Inc.10 recruiting
Amy Gelfand10 recruiting
All India Institute of Medical Sciences10 recruiting
Charite University, Berlin, Germany10 recruiting
Centre Hospitalier Universitaire de Besancon10 recruiting
Geographic activity
United States34trials
Germany11trials
Italy9trials
Spain9trials
United Kingdom9trials
Denmark7trials
Canada6trials
France6trials
Netherlands5trials
Czechia5trials
Poland5trials
South Korea5trials
Leading interventions
Rimegepant2trials
Acupuncture2trials
Galcanezumab2trials
Transcranial direct current stimulation2trials
Eptinezumab2trials
Atogepant2trials
Art-therapy1trials
Anisodine Hydrobromide1trials
Botulinum Toxin Type A 50 IU1trials
Botulinum Toxin Type A 25 IU1trials
Botulinum toxin type A1trials
Anodal tDCS1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.